Scopolamine Transdermal System — FDA Drug Shortage
The FDA lists a drug shortage record for Scopolamine Transdermal System (transdermal system) from Padagis US LLC with status No longer listed by FDA. The shortage was first posted on Nov 3, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Padagis US LLC
- Package NDC
- 45802-580-46
- Dosage Form
- Transdermal System
- Presentation
- Scopolamine, Transdermal System, 1 mg (NDC 45802-580-46)
- Initial Posting
- Nov 3, 2025